Number of the records: 1  

Randomized double-blind, placebo-controlled multicenter phase III study of prevention of irinotecan-induced diarrhea by a probiotic mixture containing Bifidobacterium BB-12®Lactobacillus rhamnosus LGG® in colorectal cancer patients

  1. TitleRandomized double-blind, placebo-controlled multicenter phase III study of prevention of irinotecan-induced diarrhea by a probiotic mixture containing Bifidobacterium BB-12®Lactobacillus rhamnosus LGG® in colorectal cancer patients
    Author infoMego M. ... [et al.]
    Co-authors Mego Michal
    Daniš Radoslav
    Chovanec Jozef 1951-
    Jurišová Silvia
    Bystrický Branislav
    Pörsök Štefan
    Konkolovský Peter
    Václav Vladimír
    Wagnerová Mária
    Streško Marian
    Brezinová Bibiána
    Rečková Mária
    Šuteková Dagmar
    Pazderová Natália

    Novisedláková Mária
    Zomborská Eva
    Čierniková Soňa
    Světlovská Daniela
    Drgoňa Ľuboš
    Corporation Redakcia Onkológia
    NoteFrontiers in oncology, vol. 13, August 4 (2023), s. 1168654
    Sign.C 3069
    Source Onkológia. - ISSN 1336-8176. - Bratislava : SOLEN , 2023 . - Roč. 18, č. 4 (2023), s. 304
    MeSH Subject irinotekan : účinky nežiaduce
    hnačka : prevencia a kontrola
    probiotiká : použitie terapeutické
    Form, Genre abstrakt v angličtine
    LanguageEnglish
    CountrySlovak Republic
    Document kindRozpis článkov z periodík
    DatabaseARTICLES
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.